Medicated Skin Care in Romania
The highest share of sales in this category is held by lotion and cream/ointment acne treatments (over 90%). Pad and stick/wand products remained negligible, as they represented a new concept and Romanians continued to be conservative in terms of product formats. Meanwhile, while acne sufferers in the smaller cities and villages often tend to neglect acne unless it is very bad, when they generally seek a medical recommendation, the level of self-medication increased rapidly in Bucharest and...
Euromonitor International's Medicated Skin Care in Romania report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International's Medicated Skin Care in Romania report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Medicated Skin Care market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
Table 3 Medicated Skin Care Company Shares by Value 2007-2011
Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
Table 5 Hair Loss Treatments Brand Shares by Value 2008-2011
Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Antibiotice SA in Consumer Health (romania)
Strategic Direction
Key Facts
Summary 1 Antibiotice SA: Key Facts
Summary 2 Antibiotice SA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 Antibiotice SA: Competitive Position 2011
Biofarm SA in Consumer Health (romania)
Strategic Direction
Key Facts
Summary 4 Biofarm SA: Key Facts
Summary 5 Biofarm SA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 6 Biofarm SA: Competitive Position 2011
Zentiva SA in Consumer Health (romania)
Strategic Direction
Key Facts
Summary 7 Zentiva SA: Key Facts
Summary 8 Zentiva SA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 9 Zentiva SA: Competitive Position 2011
Executive Summary
the Market Grows in 2011, More in Value Than in Volume
Hospital Expenses Reach Around 13% of the Total Market, While the Retail Covers the Rest
Expenses for Health Remain Among Slowest in Europe
Chemists and Pharmacies Lead Distribution
Market Has Good Growth Potential
Key Trends and Developments
Clawback Tax Could Have Strong Impact on Market
General Health and Wellness Trend Likely To Have Positive Effect
Demographic Factor Likely To Encourage Growth
Pharmaceutical Channel Increasingly Concentrated
Market Highly Regulated and Highly Taxed
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 9 Life Expectancy at Birth 2006-2011
Market Data
Table 10 Sales of Consumer Health by Category: Value 2006-2011
Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 12 Consumer Health Company Shares 2007-2011
Table 13 Consumer Health Brand Shares 2008-2011
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 10 OTC-Switches 2009-2011
Sources
Summary 11 Research Sources
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
Table 3 Medicated Skin Care Company Shares by Value 2007-2011
Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
Table 5 Hair Loss Treatments Brand Shares by Value 2008-2011
Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Antibiotice SA in Consumer Health (romania)
Strategic Direction
Key Facts
Summary 1 Antibiotice SA: Key Facts
Summary 2 Antibiotice SA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 Antibiotice SA: Competitive Position 2011
Biofarm SA in Consumer Health (romania)
Strategic Direction
Key Facts
Summary 4 Biofarm SA: Key Facts
Summary 5 Biofarm SA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 6 Biofarm SA: Competitive Position 2011
Zentiva SA in Consumer Health (romania)
Strategic Direction
Key Facts
Summary 7 Zentiva SA: Key Facts
Summary 8 Zentiva SA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 9 Zentiva SA: Competitive Position 2011
Executive Summary
the Market Grows in 2011, More in Value Than in Volume
Hospital Expenses Reach Around 13% of the Total Market, While the Retail Covers the Rest
Expenses for Health Remain Among Slowest in Europe
Chemists and Pharmacies Lead Distribution
Market Has Good Growth Potential
Key Trends and Developments
Clawback Tax Could Have Strong Impact on Market
General Health and Wellness Trend Likely To Have Positive Effect
Demographic Factor Likely To Encourage Growth
Pharmaceutical Channel Increasingly Concentrated
Market Highly Regulated and Highly Taxed
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 9 Life Expectancy at Birth 2006-2011
Market Data
Table 10 Sales of Consumer Health by Category: Value 2006-2011
Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 12 Consumer Health Company Shares 2007-2011
Table 13 Consumer Health Brand Shares 2008-2011
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 10 OTC-Switches 2009-2011
Sources
Summary 11 Research Sources
